3rd Quarter - Report
PODESTA GROUP, INC. for AMPHASTAR PHARMACEUTICALS, INC.
Firm
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA Reform Abbreviated New Drug Application (ANDA) process and Follow-on-Biologics
| Lobbyist | Covered position, as disclosed |
|---|---|
| RANDALL GERARD | Senate Commerce, Science & Transportation |
| ARANTHAN JONES | Health Policy Dir., Congressional Black Caucus |
| THOMAS B SPARKMAN | Health Policy Intern, Senate HELP Committee |
| NICOLE C YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.